Logo

Paracel Sells GeneMatcher Analysis Engine to Incyte

Dec 31, 1999
Premium

P

ASADENA, Calif.--Paracel announced last month that Incyte Pharmaceuticals has purchased Paracel’s massively parallel genetic data analysis engine for high-throughput search and annotation, GeneMatcher. Steve Lincoln, Incyte’s vice-president for bioinformatics R&D, said GeneMatcher is particularly well-suited for the high-thoughput application of hidden Markov models. "The scientific accuracy of GeneMatcher is an important element in Incyte’s ability to develop valuable databases for medical researchers," he added.

Filed under

Informatics
Breaking News
The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.